NDC 60270-854-17 - C-M-P-K
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60270-854
- Requested NDC
- 60270-854-17
- Package NDCs from labels
- 60270-854-17
- Manufacturer
- VetTek
- Effective date
- 2025-07-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| C-M-P-K - VetTek | VetTek | 2025-07-08 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60270-854-17 | C-M-P-K | 500 mL in 1 BOTTLE, PLASTIC | INJECTION, SOLUTION | 500 | 3 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CALCIUM GLUCONATE MONOHYDRATE | ACTIVE INGREDIENT | CZN0MI5R31 | C-M-P-K INJECTION, SOLUTION [VETTEK] | 1 | |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | LX22YL083G | C-M-P-K INJECTION, SOLUTION [VETTEK] | 1 | |
| MAGNESIUM GLUCONATE | ACTIVE INGREDIENT | T42NAD2KHC | C-M-P-K INJECTION, SOLUTION [VETTEK] | 1 | |
| PHOSPHORUS | ACTIVE INGREDIENT | 27YLU75U4W | C-M-P-K INJECTION, SOLUTION [VETTEK] | 1 | |
| POTASSIUM CHLORIDE | ACTIVE INGREDIENT | 660YQ98I10 | C-M-P-K INJECTION, SOLUTION [VETTEK] | 1 | |
| ANHYDROUS DEXTROSE | ACTIVE MOIETY | 5SL0G7R0OK | C-M-P-K INJECTION, SOLUTION [VETTEK] | 1 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | C-M-P-K INJECTION, SOLUTION [VETTEK] | 1 | |
| MAGNESIUM CATION | ACTIVE MOIETY | T6V3LHY838 | C-M-P-K INJECTION, SOLUTION [VETTEK] | 1 | |
| PHOSPHORUS | ACTIVE MOIETY | 27YLU75U4W | C-M-P-K INJECTION, SOLUTION [VETTEK] | 1 | |
| POTASSIUM CATION | ACTIVE MOIETY | 295O53K152 | C-M-P-K INJECTION, SOLUTION [VETTEK] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Potassium Chloride | POTASSIUM CHLORIDE | Henry Schein, Inc. | bf8e8ac7-e6a8-4571-a0ea-7bcab89290f6 | 2026-11-06 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Henry Schein, Inc. | 8367a2ae-dfd9-4515-838c-529920291ca0 | 2026-11-06 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Par Health | a64d7151-09a6-474c-83fc-36c7cf582d32 | 2026-11-05 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | Bryant Ranch Prepack | 8bae6f0f-58ca-490f-a725-8ec4bc6ba514 | 2026-11-03 | Warnings, Adverse reactions | 660YQ98I10 |
| Delflex | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care de Mexico, S.A. de C.V. | a98facd6-9daa-4d37-8209-63a0599dbfaa | 2026-10-30 | Warnings, Adverse reactions | LX22YL083G |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | c29bdfa0-4976-11e2-939b-0002a5d5c51b | 2026-10-30 | Warnings, Adverse reactions | LX22YL083G |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | bbc5b820-4973-11e2-a192-0002a5d5c51b | 2026-10-30 | Warnings, Adverse reactions | LX22YL083G |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | 515dcee0-3e34-11e2-a25f-0800200c9a66 | 2026-10-30 | Warnings, Adverse reactions | LX22YL083G |
| Potassium Chloride | POTASSIUM CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 47a87fb6-5e61-41c9-b759-10f7c74a67ce | 2026-10-30 | Warnings, Adverse reactions | 660YQ98I10 |
| Lactated Ringers | SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM LACTATE AND CALCIUM CHLORIDE | Sportpharm LLC | b809de66-be11-46c8-b1b4-ab32bc6faee2 | 2026-10-28 | Warnings, Adverse reactions | 660YQ98I10 |
| Calcium Gluconate | CALCIUM GLUCONATE | Henry Schein, Inc. | 3cbf6bf7-2415-4435-b3df-41855514a05d | 2026-10-27 | Warnings, Adverse reactions | CZN0MI5R31 |
| Potassium Chloride | POTASSIUM CHLORIDE | A-S Medication Solutions | 030b8852-258d-435d-8bf4-8d7d591c1c8a | 2026-10-26 | Warnings, Adverse reactions | 660YQ98I10 |
| Heparin Sodium in Dextrose | HEPARIN SODIUM AND DEXTROSE | B. Braun Medical Inc. | 92a6f533-1a3d-4734-b413-d245592454e3 | 2026-10-26 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | ProPharma Distribution | 5dceb1b4-e97a-a4fd-e063-6394a90a0392 | 2026-10-14 | Warnings, Adverse reactions | LX22YL083G |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | PD-Rx Pharmaceuticals, Inc. | cc15ef60-6956-4d34-b86d-72cdd0c0c0bb | 2026-10-14 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | PD-Rx Pharmaceuticals, Inc. | ccaaa3a2-a273-41c7-9e54-429539ea0140 | 2026-10-14 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 018fc687-1fba-202e-e063-6294a90a5c9a | 2026-10-14 | Warnings, Adverse reactions | 660YQ98I10 |
| KLOR-CON M | POTASSIUM CHLORIDE | Cardinal Health 107, LLC | ee3a1815-7325-4838-9764-fe1db68877b6 | 2026-10-13 | Warnings, Adverse reactions | 660YQ98I10 |
| Isolyte S pH 7.4 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE | B. Braun Medical Inc. | 150437b6-320e-4c69-a434-2a26a1f0b2e4 | 2026-10-12 | Warnings, Adverse reactions | 660YQ98I10 |
| Isolyte S | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | B. Braun Medical Inc. | 7e8fe27f-ff82-48c1-9bf6-3c589c8e985d | 2026-10-12 | Warnings, Adverse reactions | 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.